Orthofix Medical Inc (OFIX) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.040x

Based on the latest financial reports, Orthofix Medical Inc (OFIX) has a cash flow conversion efficiency ratio of -0.040x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-17.61 Million) by net assets ($435.19 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Orthofix Medical Inc fund operations to measure how many days the company can operate on defensive assets alone.

Orthofix Medical Inc - Cash Flow Conversion Efficiency Trend (1992–2025)

This chart illustrates how Orthofix Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Orthofix Medical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orthofix Medical Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Sprout Social Inc
NASDAQ:SPT
0.117x
Zhongxing Shenyang Commercial Building Group Co Ltd
SHE:000715
0.029x
TAIDOC TECHNOLOGY CORP
TW:4736
0.024x
Chongqing YuXin Pingrui Electronic Co. Ltd.
SHE:301107
0.011x
Enseval Putra Megatrading Tbk
JK:EPMT
0.035x
Hyundai Motor S3 Pref
KO:005389
-0.016x
ANGLO ASIAN MINING
F:A4A
N/A
Beijing Airport High-Tech Park Co Ltd
SHG:600463
0.008x

Annual Cash Flow Conversion Efficiency for Orthofix Medical Inc (1992–2025)

The table below shows the annual cash flow conversion efficiency of Orthofix Medical Inc from 1992 to 2025. For the full company profile with market capitalisation and key ratios, see Orthofix Medical Inc market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $450.04 Million $33.35 Million 0.074x +44.55%
2024-12-31 $503.12 Million $25.79 Million 0.051x +167.08%
2023-12-31 $598.73 Million $-45.75 Million -0.076x -123.10%
2022-12-31 $336.86 Million $-11.54 Million -0.034x -162.47%
2021-12-31 $336.93 Million $18.48 Million 0.055x -73.65%
2020-12-31 $356.86 Million $74.27 Million 0.208x +112.87%
2019-12-31 $327.63 Million $32.03 Million 0.098x -34.31%
2018-12-31 $335.40 Million $49.92 Million 0.149x -17.24%
2017-12-31 $296.61 Million $53.34 Million 0.180x +5.99%
2016-12-31 $263.48 Million $44.71 Million 0.170x +13.96%
2015-12-31 $290.31 Million $43.22 Million 0.149x -12.46%
2014-12-31 $299.63 Million $50.96 Million 0.170x -21.53%
2013-12-31 $311.18 Million $67.44 Million 0.217x +671.90%
2012-12-31 $399.10 Million $11.21 Million 0.028x -86.34%
2011-12-31 $315.17 Million $64.78 Million 0.206x +45.61%
2010-12-31 $300.89 Million $42.47 Million 0.141x -32.13%
2009-12-31 $240.27 Million $49.97 Million 0.208x +56.98%
2008-12-31 $202.06 Million $26.77 Million 0.132x +167.45%
2007-12-31 $433.94 Million $21.50 Million 0.050x +138.04%
2006-12-31 $392.63 Million $8.17 Million 0.021x -92.80%
2005-12-31 $368.88 Million $106.67 Million 0.289x +212.66%
2004-12-31 $297.17 Million $27.48 Million 0.092x -29.95%
2003-12-31 $240.78 Million $31.79 Million 0.132x -19.83%
2002-12-31 $177.95 Million $29.30 Million 0.165x +26.93%
2001-12-31 $145.43 Million $18.87 Million 0.130x -67.39%
2000-12-31 $141.51 Million $56.31 Million 0.398x +357.70%
1999-12-31 $97.20 Million $8.45 Million 0.087x +24.90%
1998-12-31 $86.20 Million $6.00 Million 0.070x +5.62%
1997-12-31 $69.80 Million $4.60 Million 0.066x +102.80%
1996-12-31 $67.70 Million $2.20 Million 0.032x -57.48%
1995-12-31 $61.50 Million $4.70 Million 0.076x -59.96%
1994-12-31 $46.10 Million $8.80 Million 0.191x -27.35%
1993-12-31 $37.30 Million $9.80 Million 0.263x +133.18%
1992-12-31 $28.40 Million $3.20 Million 0.113x --

About Orthofix Medical Inc

NASDAQ:OFIX USA Medical Devices
Market Cap
$373.09 Million
Market Cap Rank
#13894 Global
#3283 in USA
Share Price
$9.23
Change (1 day)
-1.91%
52-Week Range
$9.20 - $16.23
All Time High
$67.71
About

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhanc… Read more